AFRICA today represents one of the most compelling opportunity frontiers of the 21st century. With rapidly growing demand, expanding markets, and accelerating innovation, our continent is increasingly positioned to convert long-standing structural challenges into engines of growth. Nowhere is this opportunity more evident – and more urgent – than in Africa’s health sector.
For too long, Africa’s health sector has been defined solely by its unmet needs. That narrative is incomplete and outdated. Today, our health economy is defined by scale, productivity potential, and its central role in industrialisation, job creation, human capital development, and long-term economic resilience. The question is no longer whether Africa’s health sector can transform – it is how quickly we can mobilise the investment and partnerships required to make that transformation irreversible.
Realising this potential requires a deliberate shift: from fragmented spending to structured investment; from isolated initiatives to coherent pipelines; and from aspiration to delivery at scale. This is the mandate of the African Union Development Agency (AUDA-NEPAD). As the African Union’s development agency, we are tasked with driving the implementation of Agenda 2063 by supporting Member States to design, coordinate, and deliver priority continental programmes. Our role is to translate policy into practice – mobilising partnerships, strengthening institutional capacity, and accelerating implementation where impact matters most.
The Programme for Investment and Financing in Africa’s Health Sector (PIFAH) is a flagship expression of this mandate. Implemented by AUDA-NEPAD and anchored within the African Union system, PIFAH is designed to help Member States and partners translate national health priorities into investable opportunities capable of mobilising public and private capital. It functions as a market-building platform – bringing together policy alignment, project preparation, partnerships, and financing into a coherent continental proposition.
From Pipeline to Marketplace
Through the PIFAH Project List – Africa’s Health Market Atlas – we have created a continent-wide, structured portfolio of 253 health investment opportunities worth $2.6 billion. These are not theoretical projects. They are credible, government-endorsed initiatives spanning infrastructure, diagnostics, digital health, local manufacturing, human capital, and research innovation. They are visible, navigable, and designed to meet the clarity and governance standards that investors require.
The pipeline reflects Africa’s diversity and ambition. West Africa accounts for 44% of projects, with strong manufacturing concentrations emerging in Nigeria, Ghana, and Cameroon. East Africa represents 27% of the portfolio, led by regional integration initiatives including the EAC’s transformative manufacturing and supply chain corridor. Nearly 60% of projects are investment-ready, and 95% explicitly target underserved populations, rural communities, and women and girls.
What makes this pipeline compelling is not just its size, but its strategic coherence. Five cross-cutting themes emerge: health infrastructure and diagnostics (45% of projects), digital health and AI integration (30%), local manufacturing (13%), human capital development (9%), and research and development (2%). These are mutually reinforcing. Digital innovation strengthens supply chains and service delivery. Regional harmonisation accelerates manufacturing scale-up and market access. Sustained investment in women, youth, and skills drives innovation, productivity, and system sustainability.
Importantly, 95% of projects integrate climate and sustainability measures—renewable energy, resilient supply chains, waste management, and carbon reduction. This reflects a recognition that resilient health systems must also be climate-adaptive, capable of withstanding environmental shocks while delivering sustainable returns for communities and investors alike.
Manufacturing Sovereignty and Regional Integration
The pipeline signals a decisive shift toward health manufacturing sovereignty. More than two-thirds of projects focus on local manufacturing and health infrastructure, with priority product areas including diagnostics, medicines, vaccines, and active pharmaceutical ingredients. This is not about import substitution alone—it is about building industrial capability, retaining foreign exchange, creating skilled jobs, and strengthening our collective preparedness for future health threats.
Regional integration is central to this vision. Nearly three-quarters of projects are designed for cross-border impact, reflecting our commitment to pooled procurement, regulatory convergence, and regional delivery models. The EAC Regional Supply Chain and Manufacturing Corridor exemplifies this approach—a networked public-private partnership serving over 300 million people, addressing a $2 billion import-replacement opportunity, and structured to deliver 12-18% returns while strengthening health security across Partner States.
Ghana’s vaccine manufacturing initiative takes this further, establishing end-to-end production capacity – from antigen to fill-finish – serving national demand and positioning West Africa for export markets across ECOWAS. With $150-250 million in required investment and structured as a PPP concession, the project demonstrates how public leadership combined with private execution can anchor regional self-reliance.
Digital Health and Precision Medicine
Digital health and artificial intelligence are no longer peripheral innovations – they are system-wide enablers. Nearly all projects in our pipeline integrate digital or AI-enabled components across financing, diagnostics, surveillance, supply chains, and service delivery. Platforms like MyItura are connecting patients, providers, diagnostics, insurers, and financial institutions into interoperable ecosystems that enable affordable access to care and data-driven planning.
Africa’s genetic diversity also positions us as essential contributors to global precision medicine. The African Cancer Atlas, led by Yemaachi Biotech, is building the continent’s first pan-African, commercially licensable clinico-genomic oncology dataset. With clinical partnerships across 30 institutions in 11 countries, the initiative is generating discovery-grade tumour genomic data to support pharmaceutical partners in target discovery and biomarker development – while ensuring that next-generation cancer therapies work for African populations.
A Call for Strategic Partnership
In a global environment characterised by tightening fiscal space and evolving development finance, Africa must increasingly finance its own transformation while strategically crowding in investment. Through PIFAH, AUDA-NEPAD supports this shift by strengthening project preparation, enabling blended finance approaches, and aligning continental reforms, such as regional integration and regulatory harmonisation, with investable deal flow.
What investors and partners require is clear: visibility, standardisation, credible governance signals, and reduced transaction costs. The Health Market Atlas provides exactly that. It presents Africa’s health priorities not as disconnected needs, but as a structured pipeline of opportunities with defined financing pathways, public finance and strategic purchasing, blended finance structures, public-private partnerships, and private investment.
Africa’s health economy and health sovereignty will be built by coalitions of governments, investors, development finance institutions, innovators, and development partners working through shared platforms with common standards and clear execution pathways. Governments must submit and endorse priority projects, strengthen governance and project preparation, and align policy reforms that unlock investment confidence. Investors and DFIs must engage the pipeline early, support preparation and risk mitigation, and finance scalable projects that deliver both impact and returns.
Development partners must align technical assistance with market-building needs – project preparation, regulatory strengthening, and financing architecture. Private sector innovators must scale solutions through partnerships and regional integration, anchored in predictable standards and demand signals.
The opportunity is significant. The message is clear: Africa’s health economy is transforming. It is firmly anchored in African priorities, open to strategic partnerships, converting opportunity into investable pipelines, and building the foundations for long-term scale and resilience. With clearer standards and more predictable demand, we can unlock capital for local manufacturing, diagnostics networks, digital health platforms, research ecosystems, and resilient service delivery systems.
Health is positioned not only as a social priority, but as a growth sector capable of delivering both economic and development returns. Through PIFAH, Africa is moving from aspiration to execution – building investable health markets that strengthen resilience, expand prosperity, and deliver better health outcomes for people across the continent. The foundations are in place. The pipeline is visible. The time to invest is now.
